Publications

496 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Organisation chart 2024

    This document gives an overview of the members of the Executive Board (RvB), the management of the National Health Care Institute ...

    Publication | 11-11-2024

  2. Report - Cost-effectiveness: recommendations for surrogate endpoints

    The National Health Care Institute and similar government organisations in England, Canada, the United States, Colombia and ...

    Report | 01-11-2024

  3. Taking care of good healthcare

    Video | 03-10-2024

  4. Advice - continue reimbursing nirmatrelvir/ritonavir (Paxlovid®) for the treatment of COVID-19

    Paxlovid® can be used for treating adults with a coronavirus infection (COVID-19) and a very high risk of severe progression of ...

    Report | 18-09-2024

  5. Advice - reimburse lebrikizumab (Ebglyss®) for the treatment of moderate to severe eczema

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse lebrikizumab ...

    Report | 12-09-2024

  6. Advice - reimburse zilucoplan (Zilbrysq®) for the treatment of myasthenia gravis

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse zilucoplan ...

    Report | 29-08-2024

  7. Advice - reimburse tebentafusp (Kimmtrak®) for the treatment of eye cancer

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse tebentafusp ...

    Report | 29-08-2024

  8. Advice - expansion of the reimbursement conditions for inclisiran (Leqvio®) and bempedoic acid (Nilemdo®)

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to amend the List 2 conditions for ...

    Report | 29-08-2024

  9. Advice - reimburse olipudase alfa (Xenpozyme®) for the treatment of Niemann-Pick disease

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse olipudase alfa ...

    Report | 21-08-2024

  10. Advice - reimburse mirikizumab (Omvoh®) for the treatment of ulcerative colitis

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse mirikizumab (Omvoh®) ...

    Report | 07-08-2024